tradingkey.logo

Regeneron Pharmaceuticals Inc Says Libtayo Shows 68% Reduction In Risk Of Disease Recurrence Or Death

ReutersMay 31, 2025 12:13 PM

- Regeneron Pharmaceuticals Inc REGN.O:

  • REGENERON PHARMACEUTICALS INC - LIBTAYO SHOWS 68% REDUCTION IN RISK OF DISEASE RECURRENCE OR DEATH

  • REGENERON PHARMACEUTICALS INC - LIBTAYO SHOWS 80% REDUCTION IN LOCOREGIONAL RECURRENCE RISK

  • REGENERON PHARMACEUTICALS INC - LIBTAYO SHOWS 65% REDUCTION IN DISTANT RECURRENCE RISK

  • REGENERON PHARMACEUTICALS INC - REGULATORY APPLICATIONS SUBMITTED IN U.S. AND EU FOR LIBTAYO

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Related Articles

KeyAI